image0012.png

 

主要學歷由最高學歷依次填寫,若仍在學者,請在學位欄填「肄業」

學校名稱 國別 主修學門系所 學位
高雄醫學院醫學系 中華民國 醫學 醫學士
高雄醫學院醫學研究所 中華民國 腎臟醫學 碩士

 

現職及與專長相關之經歷 指與研究相關之專任職務,請依任職之時間先後順序由最近者往前追溯

服務機構 服務部門/系所 職稱 起訖年月(西元年/)
現職:高雄醫學大學醫學院 醫學系腎臟照護學系 教授 2009
高雄醫學大學附設醫院  內科部主任臨床教育訓練部 主任 2012
高雄醫學大學醫學院  腎臟照護學系 主任 2012
台灣腎臟醫學會 慢性腎臟病防治委員會 主任委員 2009

曾任:

高雄醫學大學附設醫院

血液透析室 主任 2008/012012/01
高雄醫學大學附設醫院 門診部 主任 2011/082012/07
台灣腎臟醫學會 秘書處 秘書長 1999/012001/12
台灣腎臟醫學會 秘書處 副秘書長 1993/011998/12

 

專長

  1. 內科學
  2. 腎臟、內分泌學
  3. 流行病學

 

著作目錄

2015

  1. Association of n-3 polyunsaturated fatty acids and inflammatory indicators with renal function decline in type 2 diabetes. Chung HF, Long KZ, Hsu CC, Al Mamun A, Jhang HR, Shin SJ, Hwang SJ, Huang MC. Clin Nutr. 2015 Apr;34(2):229-34.
  2. Trends of cost and mortality of patients on haemodialysis with end stage renal disease. Chang YK, Hsu CC, Chen PC, Chen YS, Hwang SJ, Li TC, Huang CC, Li CY, Sung FC. Nephrology (Carlton). 2015 Apr;20(4):243-9.
  3. Comparison of dementia risk between end stage renal disease patients with hemodialysis and peritoneal dialysis--a population based study. Lin YT, Wu PH, Kuo MC, Chen CS, Chiu YW, Yang YH, Lin MY, Hwang SJ, Chen HC. Sci Rep. 2015 Feb 23;5:8224.
  4. Association of fluid overload with cardiovascular morbidity and all-cause mortality in stages 4 and 5 CKD. Tsai YC, Chiu YW, Tsai JC, Kuo HT, Hung CC, Hwang SJ, Chen TH, Kuo MC, Chen HC. Clin J Am Soc Nephrol. 2015 Jan 7;10(1):39-46.
  5. Urinary neutrophil gelatinase-associated lipocalin and clinical outcomes in chronic kidney disease patients. Lin HY, Hwang DY, Lee SC, Kuo HT, Kuo MC, Chang JM, Tsai JC, Hung CC, Hwang SJ, Chen HC. Clin Chem Lab Med. 2015 Jan;53(1):73-83.
  6. Association of dialysis with the risks of cancers. Lin MY, Kuo MC, Hung CC, Wu WJ, Chen LT, Yu ML, Hsu CC, Lee CH, Chen HC, Hwang SJ. PLoS One. 2015 Apr 13;10(4):e0122856.
  7. Impact of Weaning from Acute Dialytic Therapy on Outcomes of Chronic Kidney Disease following Urgent-Start Dialysis. Chen YM, Li WY, Wu VC, Wang YC, Hwang SJ, Lin SH, Wu KD. PLoS One. 2015 Apr 9;10(4):e0123386.

 

2014

  1. Reply to the comments on "progression of stages 3b to 5 chronic kidney disease--preliminary results of Taiwan National Pre-ESRD Disease Management Program in Southern Taiwan" by Chen et al. Lin CM, Yang MC, Hwang SJ, Sung JM. J Formos Med Assoc. 2014 Dec;113(12):983-4.
  2. Dipyridamole treatment is associated with improved renal outcome and patient survival in advanced chronic kidney disease. Hung CC, Yang ML, Lin MY, Lin HY, Lim LM, Kuo HT, Hwang SJ, Tsai JC, Chen HC. Kaohsiung J Med Sci. 2014 Dec;30(12):599-607.
  3. Low serum calcium is associated with poor renal outcomes in chronic kidney disease stages 3-4 patients. Lim LM, Kuo HT, Kuo MC, Chiu YW, Lee JJ, Hwang SJ, Tsai JC, Hung CC, Chen HC. BMC Nephrol. 2014 Nov 21;15:183.
  4. Systolic blood pressure and outcomes in stage 3-4 chronic kidney disease patients: evidence from a Taiwanese cohort. Chiang HP, Lee JJ, Chiu YW, Tsai JC, Hung CC, Hwang SJ, Chen HC. Am J Hypertens. 2014 Nov;27(11):1396-407.
  5. Effects of the mTOR inhibitor rapamycin on monocyte-secreted chemokines. Lin HY, Chang KT, Hung CC, Kuo CH, Hwang SJ, Chen HC, Hung CH, Lin SF. BMC Immunol. 2014 Sep 26;15:37.
  6. Adiponectin gene (ADIPOQ) polymorphisms correlate with the progression of nephropathy in Taiwanese male patients with type 2 diabetes. Chung HF, Long KZ, Hsu CC, Mamun AA, Chiu YF, Tu HP, Chen PS, Jhang HR, Hwang SJ, Huang MC. Diabetes Res Clin Pract. 2014 Aug;105(2):261-70.
  7. Evaluation of vancomycin dosing protocols to achieve therapeutic serum concentrations in patients receiving high-flux haemodialysis. Lin SY, Shen MC, Hwang SJ, Chen YH, Chen TC, Chiu YW, Lu PL. Int J Antimicrob Agents. 2014 Apr;43(4):384-5.
  8. Associations between dietary patterns and kidney function indicators in type 2 diabetes. Hsu CC, Jhang HR, Chang WT, Lin CH, Shin SJ, Hwang SJ, Huang MC. Clin Nutr. 2014 Feb;33(1):98-105.
  9. High hepatitis B virus surface antigen levels and favorable interleukin 28B genotype predict spontaneous hepatitis C virus clearance in uremic patients. Yu ML, Dai CY, Huang CF, Lee JJ, Yeh ML, Yeh SM, Kuo HT, Huang JF, Chang JM, Chen HC, Juo SH, Hwang SJ, Chuang WL; FORMOSA-LIKE group. J Hepatol. 2014 Feb;60(2):253-9.
  10. Association of fluid overload with kidney disease progression in advanced CKD: a prospective cohort study. Tsai YC, Tsai JC, Chen SC, Chiu YW, Hwang SJ, Hung CC, Chen TH, Kuo MC, Chen HC. Am J Kidney Dis. 2014 Jan;63(1):68-75.
  11. Discrepancy between serological and virological analysis of viral hepatitis in hemodialysis patients. Chang JM, Huang CF, Chen SC, Dai CY, Yeh ML, Huang JF, Kuo HT, Chuang WL, Yu ML, Hwang SJ, Chen HC. Int J Med Sci. 2014 Mar 8;11(5):436-41.
  12. Fluid overload, pulse wave velocity, and ratio of brachial pre-ejection period to ejection time in diabetic and non-diabetic chronic kidney disease. Tsai YC, Chiu YW, Kuo HT, Chen SC, Hwang SJ, Chen TH, Kuo MC, Chen HC. PLoS One. 2014 Nov 11;9(11):e111000.
  13. Association of angiopoietin-2 with renal outcome in chronic kidney disease. Tsai YC, Chiu YW, Tsai JC, Kuo HT, Lee SC, Hung CC, Lin MY, Hwang SJ, Kuo MC, Chen HC. PLoS One. 2014 Oct 3;9(10):e108862.
  14. P wave dispersion and maximum P wave duration are associated with renal outcomes in chronic kidney disease. Huang JC, Wei SY, Chen SC, Chang JM, Hung CC, Su HM, Hwang SJ, Chen HC. PLoS One. 2014 Jul 9;9(7):e101962.
  15. Hepatitis C virus infection increases risk of developing end-stage renal disease using competing risk analysis. Lee JJ, Lin MY, Chang JS, Hung CC, Chang JM, Chen HC, Yu ML, Hwang SJ. PLoS One. 2014 Jun 27;9(6):e100790.
  16. Modification of diet in renal disease (MDRD) study and CKD epidemiology collaboration (CKD-EPI) equations for Taiwanese adults. Chen LI, Guh JY, Wu KD, Chen YM, Kuo MC, Hwang SJ, Chen TH, Chen HC. PLoS One. 2014 Jun 13;9(6):e99645.
  17. Association of relatives of hemodialysis patients with metabolic syndrome, albuminuria and Framingham Risk Score. Huang JC, Chen SC, Lin MY, Chang JM, Hwang SJ, Tsai JC, Chen HC. PLoS One. 2014 May 7;9(5):e96362.
  18. Variability in estimated glomerular filtration rate by area under the curve predicts renal outcomes in chronic kidney disease. Chen SC, Lin MY, Huang TH, Hung CC, Chiu YW, Chang JM, Tsai JC, Hwang SJ, Chen HC. ScientificWorldJournal. 2014;2014:802037.

 

2013

  1. Progression of stages 3b-5 chronic kidney disease--preliminary results of Taiwan national pre-ESRD disease management program in Southern Taiwan. Lin CM, Yang MC, Hwang SJ, Sung JM. J Formos Med Assoc. 2013 Dec;112(12):773-82.
  2. Terlipressin-induced hyponatremic encephalopathy in a noncirrhotic patient. Wang YK, Hwang DY, Wang SS, Hwang SJ, Chen LT, Kuo MC. Kaohsiung J Med Sci. 2013 Dec;29(12):691-4.
  3. Association of metabolic syndrome and albuminuria with cardiovascular risk in occupational drivers. Chen SC, Chang JM, Lin MY, Hou ML, Tsai JC, Hwang SJ, Chen HC. Int J Mol Sci. 2013 Nov 6;14(11):21997-2010.
  4. Association of cholesterol levels with mortality and cardiovascular events among patients with CKD and different amounts of proteinuria. Chen SC, Hung CC, Tsai YC, Huang JC, Kuo MC, Lee JJ, Chiu YW, Chang JM, Hwang SJ, Chen HC. Clin J Am Soc Nephrol. 2013 Nov;8(11):1915-26.
  5. Dialysis initiation: what's the rush? Rosansky SJ, Cancarini G, Clark WF, Eggers P, Germaine M, Glassock R, Goldfarb DS, Harris D, Hwang SJ, Imperial EB, Johansen KL, Kalantar-Zadeh K, Moist LM, Rayner B, Steiner R, Zuo L. Semin Dial. 2013 Nov-Dec;26(6):650-7.
  6. Prevalence of and associated factors with chronic kidney disease in human immunodeficiency virus-infected patients in Taiwan. Hsieh MH, Lu PL, Kuo MC, Lin WR, Lin CY, Lai CC, Tsai JJ, Chen TC, Hwang SJ, Chen YH. J Microbiol Immunol Infect. 2013 Oct 7. pii: S1684-1182(13)00158-8.
  7. Hepatitis C virus itself is a causal risk factor for chronic kidney disease beyond traditional risk factors: a 6-year nationwide cohort study across Taiwan. Chen YC, Chiou WY, Hung SK, Su YC, Hwang SJ. BMC Nephrol. 2013 Sep 6;14:187.
  8. Effects of a self-management program on patients with early-stage chronic kidney disease: a pilot study. Lin CC, Tsai FM, Lin HS, Hwang SJ, Chen HC. Appl Nurs Res. 2013 Aug;26(3):151-6.
  9. Hypokalemia, its contributing factors and renal outcomes in patients with chronic kidney disease. Wang HH, Hung CC, Hwang DY, Kuo MC, Chiu YW, Chang JM, Tsai JC, Hwang SJ, Seifter JL, Chen HC. PLoS One. 2013 Jul 2;8(7):e67140.
  10. Performance of the Framingham risk score in patients receiving hemodialysis. Huang JC, Chen SC, Su HM, Chang JM, Hwang SJ, Chen HC. Nephrology (Carlton). 2013 Jul;18(7):510-5.
  11. Dyslipoproteinemia and impairment of renal function in diabetic kidney disease: an analysis of animal studies, observational studies, and clinical trials. Hung CC, Tsai JC, Kuo HT, Chang JM, Hwang SJ, Chen HC. Rev Diabet Stud. 2013 Summer-Fall;10(2-3):110-20.
  12. Predicting mortality of incident dialysis patients in Taiwan--a longitudinal population-based study. Wu PH, Lin YT, Lee TC, Lin MY, Kuo MC, Chiu YW, Hwang SJ, Chen HC. PLoS One. 2013 Apr 23;8(4):e61930.
  13. B7-1 expression regulates the hypoxia-driven cytoskeleton rearrangement in glomerular podocytes. Chang JM, Hwang DY, Chen SC, Kuo MC, Hung CC, Hwang SJ, Tsai JC, Chen HC. Am J Physiol Renal Physiol. 2013 Jan 1;304(1):F127-36.
  14. Factors associated with CKD in the elderly and nonelderly population. Lin MY, Chiu YW, Lee CH, Yu HY, Chen HC, Wu MT, Hwang SJ. Clin J Am Soc Nephrol. 2013 Jan;8(1):33-40.
  15. Left atrial diameter and albumin with renal outcomes in chronic kidney disease. Chen SC, Chang JM, Tsai YC, Huang JC, Su HM, Hwang SJ, Chen HC. Int J Med Sci. 2013;10(5):575-84.
  16. Ratio of transmitral E-wave velocity to early diastole mitral annulus velocity with cardiovascular and renal outcomes in chronic kidney disease. Chen SC, Chang JM, Tsai YC, Huang JC, Chen LI, Su HM, Hwang SJ, Chen HC. Nephron Clin Pract. 2013;123(1-2):52-60.
  17. Is fluid overload more important than diabetes in renal progression in late chronic kidney disease? Tsai YC, Tsai JC, Chiu YW, Kuo HT, Chen SC, Hwang SJ, Chen TH, Kuo MC, Chen HC. PLoS One. 2013 Dec 9;8(12):e82566.
  18. High cost and low survival rate in high comorbidity incident elderly hemodialysis patients. Lin YT, Wu PH, Kuo MC, Lin MY, Lee TC, Chiu YW, Hwang SJ, Chen HC. PLoS One. 2013 Sep 9;8(9):e75318.
  19. Framingham risk score with cardiovascular events in chronic kidney disease. Chen SC, Su HM, Tsai YC, Huang JC, Chang JM, Hwang SJ, Chen HC. PLoS One. 2013;8(3):e60008.
  20. Association of dyslipidemia with renal outcomes in chronic kidney disease. Chen SC, Hung CC, Kuo MC, Lee JJ, Chiu YW, Chang JM, Hwang SJ, Chen HC. PLoS One. 2013;8(2):e55643.

 

2012

  1. Association of interleg BP difference with overall and cardiovascular mortality in hemodialysis. Chen SC, Chang JM, Tsai YC, Tsai JC, Su HM, Hwang SJ, Chen HC. Clin J Am Soc Nephrol. 2012 Oct;7(10):1646-53.
  2. The chronic kidney disease self-efficacy (CKD-SE) instrument: development and psychometric evaluation. Lin CC, Wu CC, Anderson RM, Chang CS, Chang SC, Hwang SJ, Chen HC. Nephrol Dial Transplant. 2012 Oct;27(10):3828-34.
  3. Prescriptions for angiotensin-converting enzyme inhibitors/angiotensin receptor blockers and monitoring of serum creatinine and potassium in patients with chronic kidney disease. Wang PT, Huang YB, Lin MY, Chuang PF, Hwang SJ. Kaohsiung J Med Sci. 2012 Sep;28(9):477-83.
  4. Prevalence of chronic kidney disease in China. Hwang SJ, Lin MY, Chen HC. Lancet. 2012 Jul 21;380(9838):213; author reply 214-6.
  5. Association of symptoms of depression with progression of CKD. Tsai YC, Chiu YW, Hung CC, Hwang SJ, Tsai JC, Wang SL, Lin MY, Chen HC. Am J Kidney Dis. 2012 Jul;60(1):54-61.
  6. Increasing prevalence of peripheral artery occlusive disease in hemodialysis patients: a 2-year follow-up. Chen SC, Su HM, Chang JM, Liu WC, Tsai JC, Tsai YC, Lin MY, Hwang SJ, Chen HC. Am J Med Sci. 2012 Jun;343(6):440-5.
  7. A comparative assessment of survival between propensity score-matched patients with peritoneal dialysis and hemodialysis in Taiwan. Chang YK, Hsu CC, Hwang SJ, Chen PC, Huang CC, Li TC, Sung FC. Medicine (Baltimore). 2012 May;91(3):144-51.
  8. Chronic kidney disease prevention--a challenge for Asian countries: report of the Third Asian Forum of Chronic Kidney Disease Initiatives. Chang JM, Hwang SJ, Tsukamoto Y, Chen HC. Clin Exp Nephrol. 2012 Apr;16(2):187-94.
  9. Association of hyperuricemia with renal outcomes, cardiovascular disease, and mortality. Liu WC, Hung CC, Chen SC, Yeh SM, Lin MY, Chiu YW, Kuo MC, Chang JM, Hwang SJ, Chen HC. Clin J Am Soc Nephrol. 2012 Apr;7(4):541-8.
  10. Echocardiographic parameters are independently associated with increased cardiovascular events in patients with chronic kidney disease. Chen SC, Chang JM, Liu WC, Huang JC, Tsai JC, Lin MY, Su HM, Hwang SJ, Chen HC. Nephrol Dial Transplant. 2012 Mar;27(3):1064-70.
  11. Stepwise increases in left ventricular mass index and decreases in left ventricular ejection fraction correspond with the stages of chronic kidney disease in diabetes patients. Chen SC, Chang JM, Liu WC, Tsai YC, Tsai JC, Su HM, Hwang SJ, Chen HC. Exp Diabetes Res. 2012;2012:789325.
  12. Vitamin D-mediated hypercalcemia as the initial manifestation of pulmonary cryptococcosis in an HIV-uninfected patient. Huang JC, Kuo MC, Hwang SJ, Hwang DY, Chen HC. Intern Med. 2012;51(13):1793-6. Epub 2012 Jul 1.
  13. Association of hsCRP, white blood cell count and ferritin with renal outcome in chronic kidney disease patients. Tsai YC, Hung CC, Kuo MC, Tsai JC, Yeh SM, Hwang SJ, Chiu YW, Kuo HT, Chang JM, Chen HC. PLoS One. 2012;7(12):e52775.
  14. Chronic kidney disease itself is a causal risk factor for stroke beyond traditional cardiovascular risk factors: a nationwide cohort study in Taiwan. Chen YC, Su YC, Lee CC, Huang YS, Hwang SJ. PLoS One. 2012;7(4):e36332.
Go to top